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Brevetoxin B ( l) ,1 a member of the “red tide"-associated class 
of marine neurotoxins»2 possesses a striking biological profile as 
a sodium channel modulator3 and a formidable molecular structure 
that includes 11 fused rings and 23 stereocenters. Several 
synthetic methods and schemes have been advanced toward the 
synthesis of this molecule,4»5 but to date, no total synthesis of 
brevetoxin B (1) or designed analogs have been reported. Herein 
we report the design and synthesis of a novel version of this 
compound, truncated brevetoxin B [AFGHIJK] (2), in which all 
the functionality within the natural compound is present, except 
for the internal rings BCDE (Figure 1). Such a design was 
considered important in that it could test the “length hypothesis* 
of the brevetoxins3*»b and provide useful information about their 
receptor.30^
An attractive bond disconnection across the oxocene ring of 
2 revealed two domains (3 and 4) that could be coupled in the 
synthetic direction via a Wittig reaction and cyclized to produce 
the desired polycyclic framework.
This convergent synthesis began with the construction of 
intermediates 3 (Scheme 1) and 4 (Scheme 2). Swern oxidation 
of the alcohol 56 (Scheme 1) followed by addition of MeMgBr 
and subsequent reoxidation gave rise to ketone 6 in 94% overall 
yield. After desilylation, the liberated alcohol 7 was converted 
to the bromoacetate ester 8, which upon exposure to (MeO)3P 
at 180 °C afforded the phosphonate 9 in 74% overall yield from 
6. A modified Homer-Emmons7 reaction was then used for the 
ring closure of 9 to 10 (88%). Reduction of 10 to the corresponding 
dihydropyran 12 was achieved by sequential treatment with 
DIBALH and BFyEtjO/EtaSiH the intermediacy of lactol
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Figure 1. Structure of truncated brevetoxin B [AFGHIJK] (2) and 
retrosynthetic analysis.
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* Reagents and conditions: (a) 2.0 equiv of (COCDi, 3.0 equiv of 
DMSO,CH2Cl2,-78  °C, then 7.0 equiv of EtjN, 1 h, 100%; (b) 2.0equiv 
of MeMgBr, THF, 0 °C, 1 h, 96%; (c) 2.0 equiv of (COCl)2, 3.0 equiv 
of DMSO, CHiClj, -78 °C, then 7.0 equiv of EtjN, 1 h, 98%; (d) 2.0 
equiv of TBAF, THF, 25 °C, 2 h, 100%; (e) 2.0 equiv of BrCH2COCi, 
4.0 equiv of pyridine, CHjCU, 0 °C, 5 h, 82%; (f) neat (MeO)3P, 180 
ftC (sealed tube), 3 h, 90%; (g) 2.0 equiv of ‘PraEtN, 2.0 equiv of UC1, 
CH3CN, 25 °C, 3 h, 88%; (h) 1.5 equiv of DIBALH, CH2C12, -78 • € ,  
0.5 h, 98%; (i) 1.0 equiv of BF3-E tA  5.0 equiv of Et3SiH, CHjCl2l -10  
°C, 0.5 h, 97%; fl) 10.0 equiv of Lit NH3, THF, -78 °C, 1.5 h, 100%; 
(k) 1.1 equiv of TsCl, 3.0 equiv of pyridine, CHjClj, 25 “C, 12 h, 70%; 
(1) 5.0 equiv of Nal, acetone, 60 °C, 12 h, 83%; (m) 1.5 equiv of TMS- 
imidazole, CH2C12, 25 °C, 0.5 h, 100%; (n) 8.0 equiv of PPh3, CHjCN, 
65 °C, 15 h, 100%. TBS -  S^BuMej, Bn «  CHjPh, TMS «  SiMe3, TsO
■ toeylate.
11 (95%). Debenzylation of 12 to the diol 13 followed by selective 
monotosylation and displacement with Nal of the primary tosylate 
14 led to 15 in 58% overall yield. Finally, protection of the 
secondary alcohol in 15 as a TMS ether and treatment with PPh3 
gave phosphonium salt 3 in quantitative yield.
The construction of aldehyde 4 commenced with diol 171 
(Scheme 2), which was first protected as an acetonide and then
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a Reagents and conditions: (a) 3.0 equiv of CH2—C(OMe)Me, 0.2 
equiv of CSA, CH2C12, 25 dC, 4 b, 89%; (b) 2.0 equiv of TBAF, THF, 
25 ftC, 2 h, 97%; (c) 2.0 equiv of (COCl)2, 3.0 equiv of DMSO, CH2Cl2l 
-78 #C, 0.5 h, then 7,0 equiv of IfoN, 100%; (d) 2.0 equiv of 
Ph3P—CHC02Me, CH2C12, 25 *C, 5 h, 96% (EiZ -  4:1); (e) H2, 
Pd(OH)2, THF, 25 *0 ,40  psi, 14 h, 100%; (0 2.0 equiv of LiAlH4l THF, 
25 °C, 4 h, 92%; (g) 1.1 equiv of TPSCI, 2.0 equiv of EtjN, 0.1 equiv 
of DMAP, CH2C12, 25 °C, 6 h, 95%; (h) 2.0 equiv of TBSOTf, 3.0 equiv 
of 2,6-lutidine, CH2C12, 0 °Ct 0.5 h, 100%; (i) 0.2 equiv of CSA, 1:1 
CH2Cl2/MeOH, 0 °C, 2 h, 87%; (j) 1.0 equiv of TBSC1, 2.0 equiv of 
Imidazole, DMF, 0 ®C, 1 h, 94%; (k) 1.5 equiv of NMO, 0.02 equiv of 
TPAP, CHjCN, 25 ttC, 1 h, 96%; (1) 3.0 equiv of EtSH, 1.1 equiv of 
Zn(OTf)2, CH2C12, 25 #C, 3 h; (m) 0.2 equiv of CSA, MeOH, 25 °C, 
1 h, 74% (over two step*); (n) 5.0 equiv of S03*pyridine, 5.0 equiv of 
EtjN, 1:1 CH2C12/D M S 0 ,0 °C, 1.5 h, 92%. TBS «  SWuMe* TPS -  
SilBuPh2, Bn *  CH2Ph, NMO ■ 4-methylmorpholine N-oxide, TPAP 
*  tetrapropylammonium perruthenate.
converted via desilylation, oxidation, and a Wittig reaction to the 
unsaturated ester 19 (ca. 4:1 E:Z isomers, 83% overall yield) 
through aldehyde 18. Sequential treatment of 19 with H2/Pd- 
(OH)2 and LiAlfy followed by selective silylation of the resulting 
hydroxyl groups furnished 23 in 87% overall yield. Removal of 
the acetonide and selective protection of the primary alcohol, 
followed by oxidation of the secondary alcohol, provided the 
corresponding ketone 26 in 79% yield. Thioketalization of 26 
and hydrolytic cleavage of the primary TBS ether afforded alcohol 
27, which was oxidized to the requisite aldehyde 4 (68% overall 
yield).
Generation of the ylide from 3, followed by reaction with 
aldehyde 4, produced the Z-olefin 28 (Scheme 3) in 57% yield 
(based on 3), Desilylation of 28, followed by AgClO^induced 
cyclization and desulfurization,9 provided oxocene 29 in 80% 
overall yield. Oxidation of 29 with PCC gave lactone 30 in 66% 
yield. Finally desilylation of 30, followed by oxidation and 
treatment of the resulting aldehyde 31 with Eschenmoser’s salt10 
secured, upon desilylation, the targeted 2 in 61% overall yield. 
X-ray crystallographic analysis of 2 (mp 218 °C, from methanol/ 
petroleum ether) confirmed its structure (sec ORTEP drawing, 
Figure 2).
Truncated brevetoxin B [AFGHIJK] (2), lacking the BCDE 
ring segment of the parent compound (1), has a head-to-tail length 
of 20.4 A as opposed to ca. 30 A1*31 for 1. Biological studies11 
with 2 revealed no binding to the brevetoxin B receptor, supporting 
the notion that the length of the molecule is crucial for biological 
activity.3t*b The described chemistry sets the stage for the total 
synthesis of the natural brevetoxin B (1) and for further chemical 
biology studies.
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* Reagents and conditions: (a) 1.0 equiv of n-BuLi, 2.0 equiv of HMPA, 
THF, -78 -*• 25 *C, 1 h, 57%; (b) 0.2 equiv of PPTS, 1:1 CH2C lj/ 
MeOH, 25 °C, I h, 91%; (c) 4*0 equiv of AgCIO*,2.0 equiv of NaHCOj, 
S i0 2, 4-A molecular sieves, CHaN02, 25 CC, 30 h, 90%; (d) 4.0 equiv 
ofPh3SnH, 0.1 equiv of AIBN, toluene, 100 *C, 2 h, 98%; (e) 8.0 equiv 
of PCC, CH2C12, 60 °C (sealed tube), 4 h, 66%; (0  2.0 equiv of TBAF, 
THF, 25 #C, 13 h, 79%; (g) 3.0 equiv of Dess-Martin periodinane, CH2C12, 
25 dC, 2 ht 100%; (h) 2.0 equiv of MeaN—CHa+I-, 20 equiv of EtjN, 
CH2C12, 25 °C, 12 H, 79%; (i) HF-pyridine, CH2Cl2, 25 °C, 30 mln, 97%. 
TBS *  Si‘BuMe2, TPS -  SitBuPh* TMS *  SiMe3.
Figure 2. ORTEP drawing of truncated brevetoxin B [AFGHUK] 2.
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